- Home
- EBMT vs ALEC Comparison
EBMT vs ALEC Comparison
Compare EBMT & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBMT
- ALEC
- Stock Information
- Founded
- EBMT 1922
- ALEC 2013
- Country
- EBMT United States
- ALEC United States
- Employees
- EBMT N/A
- ALEC N/A
- Industry
- EBMT Major Banks
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EBMT Finance
- ALEC Health Care
- Exchange
- EBMT Nasdaq
- ALEC Nasdaq
- Market Cap
- EBMT 136.9M
- ALEC 124.0M
- IPO Year
- EBMT N/A
- ALEC 2019
- Fundamental
- Price
- EBMT $16.83
- ALEC $3.07
- Analyst Decision
- EBMT
- ALEC Buy
- Analyst Count
- EBMT 0
- ALEC 7
- Target Price
- EBMT N/A
- ALEC $4.50
- AVG Volume (30 Days)
- EBMT 22.0K
- ALEC 1.1M
- Earning Date
- EBMT 10-28-2025
- ALEC 11-05-2025
- Dividend Yield
- EBMT 3.48%
- ALEC N/A
- EPS Growth
- EBMT 49.06
- ALEC N/A
- EPS
- EBMT 1.61
- ALEC N/A
- Revenue
- EBMT $84,696,000.00
- ALEC $81,130,000.00
- Revenue This Year
- EBMT N/A
- ALEC N/A
- Revenue Next Year
- EBMT $5.20
- ALEC $290.64
- P/E Ratio
- EBMT $10.36
- ALEC N/A
- Revenue Growth
- EBMT 5.13
- ALEC 46.77
- 52 Week Low
- EBMT $14.35
- ALEC $0.87
- 52 Week High
- EBMT $18.49
- ALEC $6.14
- Technical
- Relative Strength Index (RSI)
- EBMT 40.39
- ALEC 53.41
- Support Level
- EBMT $16.82
- ALEC $3.04
- Resistance Level
- EBMT $17.19
- ALEC $3.23
- Average True Range (ATR)
- EBMT 0.27
- ALEC 0.20
- MACD
- EBMT -0.07
- ALEC -0.04
- Stochastic Oscillator
- EBMT 15.84
- ALEC 41.00
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.